2026 NPPES data Physician Assistant NPI 1831559319 P.A.
Verify on CMS →

SARAH TATE, P.A.

Physician Assistant in BIRMINGHAM, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
546
Medicare Part D claims · 172 beneficiaries · Physician Assistant avg: 790
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75.1708/100
▼ 8 pts below national avg 83.1 · [object Object]

What the federal data shows

SARAH TATE, P.A. reported a CMS MIPS final score of 75.1708/100 — below the 83.1 national average — and filed 546 Medicare Part D claims in 2023.

75.1708/100
MIPS score · -8 vs avg
546
Part D claims, 2023
82%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SARAH TATE, P.A.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about SARAH TATE, P.A.?

Below national average

NPI registry status

Active

Issued 02/26/2016

NPI 1831559319

Primary specialty

Physician Assistant

High-volume

149,975 US NPIs in this specialty

Medicare Part D claims

546 31% vs specialty avg

2023 prescription claims

Specialty avg: 790

MIPS final score

75.1708/100 7.9291999999999945% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Alabama

How Physician Assistant compares to other specialties among Alabama providers

Alabama providers

Physician Assistant share within Alabama

1. Physician Assistant42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Physician Assistant share within Alabama

Medicare quality performance — MIPS

SARAH TATE, P.A.'s 2023 MIPS final score plotted against the Physician Assistant national average

Below national average
MIPS Final Score
75.1708/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Physician Assistant) — 75.1708/100 vs national avg 83.1

0%100%National avg83%75.2%
MIPS final score (Physician Assistant) — 75.1708/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARAH TATE, P.A. appears in the CMS NPPES registry as a Physician Assistant provider holding P.A. credentials at 619 19TH ST S, BIRMINGHAM, AL, 35233, with a listed phone of (205) 934-4011. NPI 1831559319 was issued on 02/26/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TATE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 546 prescription claims written by this provider, covering 172 Medicare beneficiaries and totaling roughly $154K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.1708/100 for the 2023 performance year (Quality 68.8779, Cost 54.1915), compared with the national average of 83.1.

Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

619 19TH ST S
BIRMINGHAM, AL 35233

Provider Details

NPI 1831559319
Specialty Physician Assistant
Credentials P.A.
Gender Female
NPI Issued 02/26/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75.1708
Final Score
Avg: 83.1
68.8779
Quality
54.1915
Cost
93
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SARAH TATE, P.A. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC
BIRMINGHAM, AL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

SARAH TATE, P.A. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 546 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

546
Total Claims
$154K
Total Drug Cost
172
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
807
Total Day Supply
23,527
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$129K
Generic Drug Cost
$25K

Patient Demographics

Average Patient Age
69.8 years
Avg HCC Risk Score
1.57
Gender Split
77% female / 23% male
Age Distribution
<65: 41, 65-74: 71, 75-84: 49, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SARAH TATE, P.A. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Pantoprazole Sodium
121
Colestipol Hcl
40
Famotidine
38
Dicyclomine Hcl
36
Linzess
Linaclotide
23
Loperamide
Loperamide Hcl
22
Amitriptyline Hcl
21
Creon
Lipase/Protease/Amylase
20
Omeprazole
19
Cimetidine
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Physician Assistant Overview

How SARAH TATE, P.A. fits within the Physician Assistant landscape nationally.

149,975
Physician Assistant Providers in US
56
States with Physician Assistant
790
Avg Claims per Provider

SARAH TATE, P.A.'s 546 claims are below the specialty average of 790.

Nearby Physician Assistant Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as TATE.

Compare Physician Assistant nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARAH TATE, P.A.'s specialty?
SARAH TATE, P.A. specializes in Physician Assistant and practices in BIRMINGHAM, Alabama. Credentials: P.A..
How much does SARAH TATE, P.A. prescribe under Medicare Part D?
In 2023, SARAH TATE, P.A. wrote 546 Medicare Part D claims totaling $154K in drug costs for 172 beneficiaries.
What is SARAH TATE, P.A.'s Medicare quality score?
SARAH TATE, P.A. has a CMS MIPS Final Score of 75.1708/100 (Quality: 68.8779, Cost: 54.1915). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SARAH TATE, P.A. located?
SARAH TATE, P.A. is located at 619 19TH ST S, BIRMINGHAM, AL, 35233. Phone: (205) 934-4011.
What is SARAH TATE, P.A.'s NPI number?
SARAH TATE, P.A.'s National Provider Identifier (NPI) is 1831559319, issued on 02/26/2016.
Does SARAH TATE, P.A. prescribe more brand-name or generic drugs?
SARAH TATE, P.A.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $129K in brand drug costs.
How many Physician Assistant providers are there in the US?
There are 149,975 Physician Assistant providers across 56 states in the US. The average Physician Assistant provider writes 790 Medicare Part D claims per year.
What drugs does SARAH TATE, P.A. prescribe most often?
Based on 2023 Medicare Part D data, SARAH TATE, P.A.'s most frequently prescribed drugs include Pantoprazole Sodium, Colestipol Hcl, Famotidine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARAH TATE, P.A. accept Medicare?
SARAH TATE, P.A. appears in CMS Medicare data with 546 Part D claims and 172 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARAH TATE, P.A.'s credentials?
SARAH TATE, P.A.'s NPI is 1831559319 with credentials P.A.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology